Metachromatic Leukodystrophy (MLD) - Pipeline Review 2016 Featuring ArmaGen, GlaxoSmithKline, RegenxBio & Shire - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Metachromatic Leukodystrophy (MLD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metachromatic Leukodystrophy (MLD) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Metachromatic Leukodystrophy (MLD) Overview
  3. Therapeutics Development
  4. Pipeline Products for Metachromatic Leukodystrophy (MLD) - Overview
  5. Pipeline Products for Metachromatic Leukodystrophy (MLD) - Comparative Analysis
  6. Metachromatic Leukodystrophy (MLD) - Therapeutics under Development by Companies
  7. Metachromatic Leukodystrophy (MLD) - Therapeutics under Investigation by Universities/Institutes
  8. Metachromatic Leukodystrophy (MLD) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Metachromatic Leukodystrophy (MLD) - Products under Development by Companies
  13. Metachromatic Leukodystrophy (MLD) - Products under Investigation by Universities/Institutes
  14. Metachromatic Leukodystrophy (MLD) - Companies Involved in Therapeutics Development
  • ArmaGen Inc.
  • GlaxoSmithKline Plc
  • RegenxBio Inc.
  • Shire Plc

For more information visit http://www.researchandmarkets.com/research/zh6x5n/metachromatic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System Drugs